Cash-strapped Zoono seeks A$2.1m from rights issue

Cash-strapped Zoono seeks A$2.1m from rights issue
Hand and surface sanitisers were in demand during the pandemic. (Image: Getty)
Denise McNabb
After continuing to burn cash and as its revenue plunges, Zoono Group plans to raise A$2.1 million (NZ$2.2m) through a pro-rata rights issue with free options to fund projects, a joint venture with Douglas Pharmaceuticals, China expansion and working capital. The Australian stock exchange-listed New Zealand manufacturer of antimicrobial hand and surface sanitisers announced the share offer in tandem with the release of its March 31 third-quarter report.The report details a dire future for the company unless it changes direction away from e...

More Markets

Spark's slide helps drive NZ sharemarket down
Markets Market Close

Spark's slide helps drive NZ sharemarket down

The S&P/NZX 50 Index closed at 12,166.14, down 100.11 points or 0.82%.

Graham Skellern 17 Mar 2025
Ebos shoots down pet food bid speculation
Markets

Ebos shoots down pet food bid speculation

Reports in the Australian are inaccurate, healthcare and animal care firm says.

Staff reporters 17 Mar 2025
Why Air NZ has sent its top brass to India
Markets

Why Air NZ has sent its top brass to India

Direct routes may be out of reach, but national carrier could land a deal.

Smartpay confirms dual takeover bids
Markets

Smartpay confirms dual takeover bids

The company is undertaking diligence with Tyro Payments and an unnamed international.

Staff reporters 17 Mar 2025